ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,083Medicare Part D Prescriptions Filled, Including Refills

Rank: 334 out of 6645

$900K Total Retail Price of All Prescriptions

Rank: 405 out of 6645

581 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

32% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 11,227 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 816 663 1 3
HYDROCODONE-ACETAMINOPHEN 734 434 S3 2 5
SIMVASTATIN 590 479 3 1
AMLODIPINE BESYLATE 526 430 4 2
METFORMIN HCL 448 298 5 7
OMEPRAZOLE 430 315 6 6
LEVOTHYROXINE SODIUM 424 368 7 4
FUROSEMIDE 386 308 8 11
NAPROXEN 362 266 9 88
PREDNISONE 299 207 10 57
MELOXICAM 256 192 11 46
METOPROLOL TARTRATE 248 179 12 13
ATENOLOL 238 161 13 8
FLUTICASONE PROPIONATE 237 173 14 26
HYDROCHLOROTHIAZIDE 224 161 15 9
GABAPENTIN 217 101 16 18
ZOLPIDEM TARTRATE 207 159 17 17
TRAMADOL HCL 203 133 18 30
DIOVAN 200 163 19 19
CIMETIDINE 199 164 10 20 411
METOPROLOL SUCCINATE 187 164 21 24
GLIPIZIDE 185 137 22 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 180 136 23 134
LOVASTATIN 174 142 24 15
ATORVASTATIN CALCIUM 173 146 25 10
GLYBURIDE 154 92 R 26 58
CARVEDILOL 144 111 27 25
POTASSIUM CHLORIDE 140 116 28 28
ALENDRONATE SODIUM 134 108 29 14
BENAZEPRIL HCL 130 87 30 21
TAMSULOSIN HCL 130 126 30 22
FENOFIBRATE 123 90 32 74
ALLOPURINOL 112 72 33 31
CARISOPRODOL 110 62 R 34 94
IBUPROFEN 106 72 35 42
CLOPIDOGREL 106 79 35 36
LOSARTAN POTASSIUM 104 83 37 12
LANTUS 104 56 37 50
CLONIDINE HCL 103 53 39 56
ADVAIR DISKUS 91 58 40 45
PRAVASTATIN SODIUM 91 75 40 20
PAROXETINE HCL 86 48 42 72
CIPROFLOXACIN HCL 85 61 43 67
DONEPEZIL HCL 80 64 44 27
LIPITOR 78 68 45 69
RANITIDINE HCL 78 61 45 51
FLUOXETINE HCL 77 62 47 63
VENTOLIN HFA 75 55 48 146
CYMBALTA 72 50 49 78
TRILIPIX 72 41 49 178
CITALOPRAM HBR 71 53 51 35
SPIRIVA 70 55 52 65
WARFARIN SODIUM 70 65 52 16
PROAIR HFA 70 57 52 32
ACTOS 69 50 55 71
ENALAPRIL MALEATE 67 40 56 75
PLAVIX 65 57 57 49
CYCLOBENZAPRINE HCL 64 32 R 58 157
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 50 59 37
INSULIN SYRINGE 60 44 60 61
TERAZOSIN HCL 59 55 61 48
KLOR-CON 10 56 51 62 145
DIGOXIN 54 54 63 59
ACETAMINOPHEN-CODEINE 53 45 S3 64 80
SERTRALINE HCL 52 15 65 43
ATELVIA 50 46 66 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.